Semaglutide Tablets Price: Cost, Coverage, Savings

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Welcome to the PlexusDx Education Hub, where GLP-1 science gets unpacked one honest question at a time. Browse the full Peptides & GLP-1 library to see how the topics connect.

Pricing for oral semaglutide raises the same puzzle as any GLP-1 cost question: the number quoted online and the number paid at the counter rarely match. As of April 2026, understanding the semaglutide tablets price means separating list cost from coverage, savings programs, and the compounded-oral market. This page walks through those pieces specifically for the tablet route, so the figures make sense before a prescription is filled.

As with any GLP-1 cost question, the tablet price is layered rather than fixed, and the oral route adds its own wrinkles. Coverage often tracks the diabetes indication the tablet is labeled for, which quietly shapes what many people are quoted before any card or coupon is even applied to the total.

What semaglutide tablets cost at list

Semaglutide list price runs roughly $968 to $1,029 per month at U.S. list as of April 2026, per Novo Nordisk published pricing, and the oral tablet Rybelsus sits near the top of that band at approximately $1,029 per month. That list figure is the sticker before insurance, rebates, savings cards, and pharmacy negotiation enter the picture, so it is rarely what an insured patient actually pays. What lands on the counter depends on plan design, formulary placement, prior authorization, and the indication written on the prescription.

Coverage rules for oral prescriptions

Whether a commercial plan covers oral semaglutide depends on whether the prescription is written for an FDA-approved indication and on that plan's formulary and prior-authorization criteria. Because the oral tablet is labeled for type 2 diabetes, coverage often tracks the diabetes indication, and many commercial plans do cover GLP-1 receptor agonists for that use. Coverage tied to weight management is more variable and frequently gated behind prior authorization. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026.

Savings cards, coupons, and their limits

Novo Nordisk publishes a manufacturer savings card program that can lower monthly out-of-pocket cost for eligible commercially insured patients. Eligibility typically excludes Medicare, Medicaid, TRICARE, and other government-funded insurance, and the cards carry monthly and annual caps that change over time, so terms should be checked on the manufacturer site at the time of fill. Independent discount platforms such as GoodRx and SingleCare publish separate coupon prices that vary by pharmacy, which explains why the same tablet can be quoted differently in different places.

Compounded oral pricing after the shortage era

During FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally produced compounded formulations of these molecules. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, narrowing the compounding window without eliminating all legitimate activity. Compounded oral protocols typically price below branded list, though out-of-pocket cost varies by pharmacy, prescriber, and protocol. These products are not identical to FDA-approved brands and are priced on their own terms.

Genetics before the tablet budget

Cost is one input; inherited biology is another that rarely enters the budgeting conversation. Variants in FTO, GLP1R, and MC4R shape baseline appetite and energy-balance tendencies, the terrain any oral GLP-1 decision plays out on, without predicting response or price. The Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, adding upstream context before money is committed. PlexusDx offers semaglutide through its Weight Management Protocols, including a Semaglutide Oral option, with per-protocol pricing published on each product page.

The practical upshot is that a single advertised tablet price rarely predicts a personal total. Mapping your plan, the indication on the prescription, and available oral options with a provider and pharmacist is a far better guide than any headline figure pulled from a search result or a forum post.

Frequently Asked Questions

How much do semaglutide tablets cost per month?

Oral semaglutide list price is approximately $1,029 per month at U.S. list as of April 2026, per Novo Nordisk published pricing, within the broader $968 to $1,029 range. Insurance, savings cards, and pharmacy pricing can change the counter total substantially, so confirm the current figure with the pharmacy before filling.

Does insurance cover oral semaglutide?

Coverage depends on the plan, its formulary, the FDA indication on the prescription, and prior-authorization criteria. Because the oral tablet is labeled for type 2 diabetes, coverage often follows that indication. Weight-management coverage is more variable, and Medicare does not cover weight-management indications for weight alone as of April 2026.

Are there savings options for the tablets?

Novo Nordisk publishes a manufacturer savings card for eligible commercially insured patients, and platforms like GoodRx publish separate discount prices. Government-insurance patients are typically excluded from manufacturer cards. Because caps and terms change over time, verify current details on the manufacturer site at the moment of fill.

Are compounded oral options cheaper?

Compounded oral GLP-1 protocols typically price below branded list, though out-of-pocket cost varies by pharmacy, prescriber, and protocol. They are legally and factually distinct from FDA-approved brands, not generics. PlexusDx offers semaglutide through its Weight Management Protocols, with per-protocol pricing published on each product page.

Keep exploring the PlexusDx Education Hub for more evidence-first GLP-1 guidance. Return to the education hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.